NUVB
$4.77+6.47%
Nuvation Bio Inc.Stock · HealthcareRussell 2000 · 0.04% of IWMUS Stock Market · 0.002% of VTIRussell 3000 · 0.002% of IWV
NUVB financial statements
The full income statement, balance sheet, and cash-flow statement for Nuvation Bio Inc. (NUVB), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 249.2M2024-09 336.6M2024-12 337.8M2025-03 340.3M2025-06 342.3M2025-09 342.8M2025-12 346.5M2026-03 348.2M2026-06 351.1M+40.9% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 62.9M+699.0% | 7.87M | 0.00 | — | — | |
| — | 795K | 0.00 | — | — | ||
| Cost of revenue | — | 7.08M | 0.00 | — | — | |
| 276M-54.0% | 601M+501.6% | 99.8M-16.6% | 120M+28.3% | 93.3M | ||
| Research & development | 115M+16.1% | 99.1M+39.0% | 71.3M-18.8% | 87.8M+27.2% | 69.0M | |
| Selling, general & administrative | 152M+118.9% | 69.2M+142.6% | 28.5M-10.6% | 31.9M+31.5% | 24.3M | |
| General & administrative | — | — | 28.5M-10.6% | 31.9M+31.5% | 24.3M | |
| Restructuring | — | — | — | 7.40M | — | |
| Operating income | -213M+64.0% | -593M-493.7% | -99.8M+16.6% | -120M-28.3% | -93.3M | |
| Interest expense | 13.7M+3912.3% | 341K | 0.00 | — | — | |
| Other non-operating income | 2.25M+2165.1% | -109K-100.5% | 24.0M+54.6% | 15.5M+140.1% | 6.47M | |
| Gain (loss) on equity securities | 746K+575.2% | -157K | 0.00+100.0% | -172K-3.6% | -166K | |
| Pre-tax income | -205M+64.0% | -568M-649.2% | -75.8M+27.3% | -104M-20.0% | -86.8M | |
| Income tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net income | -205M+64.0% | -568M-649.2% | -75.8M+27.3% | -104M-20.0% | -86.8M | |
| -$0.60+71.6% | -$2.11-502.9% | -$0.35+27.1% | -$0.48-9.1% | -$0.44 | ||
| EPS (basic) | -$0.60+71.6% | -$2.11-502.9% | -$0.35+27.1% | -$0.48-9.1% | -$0.44 | |
| Weighted-avg shares (basic) | 342M+27.1% | 269M+22.8% | 219M+1.0% | 217M+9.5% | 198M | |
| Weighted-avg shares (diluted) | 342M+27.1% | 269M+22.8% | 219M+1.0% | 217M+9.5% | 198M | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 572M+8.6% | 526M-14.6% | 616M-7.6% | 667M-13.6% | 772M+249.9% | ||
| Cash & equivalents | 164M+359.3% | 35.7M-16.2% | 42.6M-57.8% | 101M-23.7% | 132M+345.0% | |
| Short-term investments | 365M-21.8% | 467M-17.9% | 569M+1.5% | 560M-11.5% | 633M+240.3% | |
| Inventory | 11.4M | 0.00 | — | — | — | |
| Prepaid expenses | 11.5M+58.7% | 7.27M+378.7% | 1.52M-60.2% | 3.82M+4.9% | 3.64M+298.5% | |
| 595M+10.0% | 541M-13.0% | 621M-7.5% | 672M-13.4% | 776M+249.9% | ||
| Property, plant & equipment | 564K-3.8% | 586K-18.3% | 717K-19.8% | 894K+13.7% | 786K+14.2% | |
| Operating lease right-of-use | 3.92M+63.1% | 2.40M-33.4% | 3.60M-4.9% | 3.79M+32.0% | 2.87M | |
| Intangible assets | 11.2M+142.6% | 4.62M | 0.00 | — | — | |
| Other non-current assets | 7.61M+12.5% | 6.76M+1051.8% | 587K | 0.00 | — | |
| 82.2M+41.2% | 58.2M+316.8% | 14.0M+6.2% | 13.2M-22.2% | 16.9M+158.4% | ||
| Accounts payable | 9.48M+49.3% | 6.35M+187.4% | 2.21M+3.3% | 2.14M-45.5% | 3.92M+80.8% | |
| Accrued liabilities | 45.2M+37.6% | 32.8M+235.3% | 9.79M-0.2% | 9.82M-19.1% | 12.1M+177.1% | |
| Deferred revenue | 7.51M-32.4% | 11.1M | 0.00 | — | — | |
| Short-term & current debt | 5.72M-8.9% | 6.28M | 0.00 | — | — | |
| Current lease liability | 1.88M+13.0% | 1.66M-15.7% | 1.97M+63.5% | 1.21M+39.7% | 863K | |
| 289M+276.3% | 76.8M+369.6% | 16.4M-4.1% | 17.1M-43.4% | 30.2M+349.5% | ||
| Long-term debt | 47.2M | — | — | — | — | |
| Deferred revenue (non-current) | 146M+836.4% | 15.6M | 0.00 | — | — | |
| Non-current lease liability | 2.54M+162.4% | 969K-52.4% | 2.04M-33.4% | 3.05M+39.3% | 2.19M | |
| Operating lease liability (total) | 4.42M+68.0% | 2.63M-34.3% | 4.01M-5.9% | 4.26M+39.4% | 3.06M | |
| 306M-34.1% | 464M-23.4% | 605M-7.6% | 655M-12.2% | 746M+246.8% | ||
| Preferred stock | — | — | 0.00 | — | — | |
| Common stock | 1.42B+3.4% | 1.37B+45.0% | 948M+2.2% | 928M+1.9% | 910M+214.3% | |
| Retained earnings | -1.12B-22.5% | -911M-165.7% | -343M-28.4% | -267M-64.0% | -163M-114.3% | |
| Accumulated other comprehensive income | -187K-132.6% | 573K+216.6% | 181K+103.3% | -5.53M-366.3% | -1.19M-176.1% | |
| Total liabilities & equity | 595M+10.0% | 541M-13.0% | 621M-7.5% | 672M-13.4% | 776M+249.9% | |
| Common shares issued | 350M+3.5% | 338M+54.2% | 219M+0.2% | 219M+0.3% | 218M+46.2% | |
| Common shares outstanding | 347M+2.6% | 338M+54.2% | 219M+0.2% | 219M+0.3% | 218M+46.2% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -173M-33.0% | -130M-91.8% | -68.0M+29.2% | -96.1M-40.9% | -68.2M | ||
| Depreciation & amortization | 1.74M+154.6% | 683K+207.7% | 222K+11.6% | 199K+8.2% | 184K | |
| Share-based compensation | 35.9M+11.2% | 32.3M+65.4% | 19.5M+19.8% | 16.3M+75.8% | 9.27M | |
| Deferred income taxes | — | — | — | 0.00 | 0.00 | |
| Change in receivables | 3.35M-73.6% | 12.7M | 0.00 | — | — | |
| Change in payables | 3.13M+289.3% | -1.65M-2462.9% | 70.0K+103.9% | -1.79M-196.0% | 1.86M | |
| 99.5M-18.9% | 123M+1275.4% | 8.92M-85.9% | 63.5M+114.0% | -455M | ||
| Capital expenditure | 8.00M | 0.00 | — | — | — | |
| Free cash flow | -181M-39.1% | -130M | — | — | — | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 203M+61088.8% | 331K-47.3% | 628K-52.7% | 1.33M-99.8% | 626M | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FX effect on cash | -265K-158.5% | 453K | 0.00 | — | — | |
| Net change in cash | 128M+1953.3% | -6.93M+88.2% | -58.5M-86.6% | -31.3M-130.5% | 103M | |
| Interest paid | 2.88M+745.2% | 341K | 0.00 | — | — | |
| Income taxes paid | 197K-47.2% | 373K | 0.00 | — | — | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 3.10B+245.5% | 899M+171.8% | 331M-21.2% | 419M-77.4% | 1.85B+6.2% | |
| P/S | 49.4×-56.8% | 114.1× | — | — | — | |
| P/B | 10.2×+424.1% | 1.9×+258.4% | 0.5×-13.9% | 0.6×-74.7% | 2.5×-69.4% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: NUVB’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all NUVB filings on SEC EDGAR → Not investment advice.